Senior insider sale
MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$48.34M
90.28K shares
TAUB REBECCA plans to sell 90.28K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $48.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 491.00 | — |
| Total | 491.00 | ||
Completed
Units to sell
647.00
Market value
$318.6K
Units to sell
2.24K
Market value
$1.10M
Units to sell
18.65K
Market value
$9.75M
Units to sell
24.80K
Market value
$12.96M
Units to sell
18.65K
Market value
$10.30M
Units to sell
24.80K
Market value
$13.69M
Planned — Approximate Date
Units to sell
491.00
Market value
$215.7K
Units
90.28K
Value
$48.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 647.00 | $318.6K | — | Completed |
1/20/2026 | 2.24K | $1.10M | — | Completed |
1/9/2026 | 18.65K | $9.75M | — | Completed |
1/9/2026 | 24.80K | $12.96M | — | Completed |
12/10/2025 | 18.65K | $10.30M | — | Completed |
12/10/2025 | 24.80K | $13.69M | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 491.00 | $215.7K | Nasdaq Stock Market | Planned |
| Total | 90.28K | $48.34M | ||